mmarschik, Author at NexPoint

NexPoint Leads Series B Financing for Biotechnology Company Sapience Therapeutics

"HARRISON, N.Y., May 31, 2022 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on…

mmarschikJune 8, 2022

NEWS NXDT previously NHF PRESS RELEASE

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution – June 1, 2022

DALLAS – June 1, 2022 – NexPoint Diversified Real Estate Trust (NYSE: NXDT) (“NXDT” or…

mmarschikJune 2, 2022

NEWS PRESS RELEASE

NexPoint Sends Letter to United Development Funding IV (UDFI) Board of Trustees, Renewing Request for Board Engagement

NexPoint Seeks to Engage with UDFI Board to Maximize Shareholder Value DALLAS – May 27,…

mmarschikMay 27, 2022

NEWS PRESS RELEASE Single Family Rental Homes

NexPoint Advisors, HomeSource Launch SFR Initiative

"Multibillion-dollar alternative investment platform NexPoint Advisors L.P., has partnered with HomeSource Operations LLC, in the formation of…

mmarschikMay 20, 2022

FEATURED NEWS PRESS RELEASE Single Family Rental Homes

NexPoint Announces New Single-Family Rental Initiative

Initiative Will Focus on Acquisitions of Existing Single-Family Rental Homes and Opportunities with Build-to-Rent Communities…

mmarschikMay 19, 2022

NEWS PRESS RELEASE Single Family Rental Homes

Single-Family Rental Sector Poised for Continued Growth

May 17, 2022 Over the next decade, we believe single-family rentals will play a more…

mmarschikMay 17, 2022

Healthcare NEWS PRESS RELEASE

NexPoint Participates in Series C Financing for Apnimed, a Clinical-stage Pharmaceutical Company Focused on Treating Sleep Disorders

"CAMBRIDGE, Mass. May 4, 2022 – Apnimed, a clinical-stage pharmaceutical company focused on developing oral…

mmarschikMay 4, 2022

NXDT previously NHF PRESS RELEASE

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution

DALLAS – May 2, 2022 – NexPoint Diversified Real Estate Trust (NYSE: NXDT) (“NXDT” or…

mmarschikMay 3, 2022

NXDT previously NHF PRESS RELEASE

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution

DALLAS – April 1, 2022 – NexPoint Diversified Real Estate Trust (NYSE: NXDT) (“NXDT” or…

mmarschikApril 4, 2022

NexPoint Capital PRESS RELEASE

NexPoint Capital, Inc. Announces Tender Offer for Common Stock

NexPoint Capital, Inc. Announces Tender Offer for Common Stock DALLAS, March 29, 2022 – NexPoint…

mmarschikMarch 29, 2022

Form CRS | Important Risk Disclosures | Privacy Policy

Before investing in any of the NexPoint funds, you should carefully consider the fund’s investment objectives, risks, charges, and expenses. A copy of a fund’s prospectus, which contains this and other information, is available on the fund’s website or by calling the shareholder services at (844) 485-9167.

Please read the prospectus carefully before investing. This website is neither an offer to sell nor a solicitation of an offer to buy any of the securities described herein. An investment in any of the NexPoint offerings involves risk, and there can be no assurance that the investment objectives will be met. Past performance does not guarantee future results.

NexPoint Securities, Inc., Member FINRA/SIPC, is the distributor for NexPoint products.

Brokercheck.FINRA.org

mmarschik

NexPoint Leads Series B Financing for Biotechnology Company Sapience Therapeutics

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution – June 1, 2022

NexPoint Sends Letter to United Development Funding IV (UDFI) Board of Trustees, Renewing Request for Board Engagement

NexPoint Advisors, HomeSource Launch SFR Initiative

NexPoint Announces New Single-Family Rental Initiative

Single-Family Rental Sector Poised for Continued Growth

NexPoint Participates in Series C Financing for Apnimed, a Clinical-stage Pharmaceutical Company Focused on Treating Sleep Disorders

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution

NexPoint Capital, Inc. Announces Tender Offer for Common Stock

Follow NexPoint on LinkedIn

Contact Us

$2.7 Billion